Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
VolitionRX (VNRX)
NYSE MKT:VNRX
VolitionRX (VNRX) Stock Price & Analysis
421 Followers
VNRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $2.10
Previous Close$0.74
Volume287.76K
Average Volume (3M)190.65K
Market Cap
$60.98M
Enterprise Value$53.66M
Total Cash (Recent Filing)$10.81M
Total Debt (Recent Filing)$4.30M
Price to Earnings (P/E)-1.5
Beta1.02
Next Earnings
May 08, 2024EPS Estimate
-$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.50
Shares Outstanding82,068,442
10 Day Avg. Volume210,973
30 Day Avg. Volume190,650
Standard Deviation0.18
R-Squared0.16
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-29.43
Price to Sales (P/S)509.35
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue82.43
Enterprise Value/Gross Profit175.15
Enterprise Value/Ebitda-1.56
Forecast
1Y Price Target
$4.50Price Target Upside494.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
VolitionRX News
Ownership Overview
28.82% Insiders
1.62% Mutual Funds
5.91% Other Institutional Investors
63.66% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VNRX FAQ
What was VolitionRX’s price range in the past 12 months?
VolitionRX lowest stock price was $0.55 and its highest was $2.10 in the past 12 months.
What is VolitionRX’s market cap?
Currently, no data Available
When is VolitionRX’s upcoming earnings report date?
VolitionRX’s upcoming earnings report date is May 08, 2024 which is in 15 days.
How were VolitionRX’s earnings last quarter?
VolitionRX released its earnings results on Mar 25, 2024. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.103 by $0.003.
Is VolitionRX overvalued?
According to Wall Street analysts VolitionRX’s price is currently Undervalued.
Does VolitionRX pay dividends?
VolitionRX does not currently pay dividends.
What is VolitionRX’s EPS estimate?
VolitionRX’s EPS estimate is -$0.1.
How many shares outstanding does VolitionRX have?
VolitionRX has 82,068,440 shares outstanding.
What happened to VolitionRX’s price movement after its last earnings report?
VolitionRX reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.103. Following the earnings report the stock price went up 4.167%.
Which hedge fund is a major shareholder of VolitionRX?
Currently, no hedge funds are holding shares in VNRX
---
VolitionRX Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.50 (494.45% Upside)
$4.50 (494.45% Upside)
Blogger Sentiment
Bullish
VNRX Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $18.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 5.0%
Last 30 Days ▼ 5.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.94%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
52.78%
Trailing 12-Months
Company Description
VolitionRX
VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Austin, TX.
---
VNRX Earnings Call
Q4 2024
0:00 / 0:00
---
VNRX Stock 12 Months Forecast
Average Price Target
$4.50
▲(494.45% Upside)
Technical Analysis
Best Analysts Covering VNRX
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-31.27%
reiterated a buy rating 6 months ago
Copying Ross Osborn's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -31.27% per trade.
---